The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 04, 2018

Filed:

Aug. 02, 2016
Applicant:

Molmed, S.p.a., Milan, IT;

Inventors:

Chiara Bovolenta, Milan, IT;

Anna Stornaiuolo, Milan, IT;

Paolo Rizzardi, Milan, IT;

Fulvio Mavilio, Evry, FR;

Assignee:

MolMed, S.p.A., Milan, IT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C12N 15/867 (2006.01); C07K 14/54 (2006.01); C07K 14/005 (2006.01); A61K 39/21 (2006.01); A61K 39/00 (2006.01); C07K 16/10 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C12N 15/8673 (2013.01); A61K 38/00 (2013.01); A61K 39/21 (2013.01); A61K 2039/525 (2013.01); C07K 14/005 (2013.01); C07K 14/54 (2013.01); C07K 16/10 (2013.01); C12N 2710/14144 (2013.01); C12N 2740/16052 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14352 (2013.01); C12N 2800/40 (2013.01); C12N 2800/50 (2013.01); C12N 2810/6054 (2013.01);
Abstract

The present invention provides new stable packaging cell lines and producer cell lines as well as methods to obtain them, and a new method to produce lentiviral vectors using such cell lines. New methods and packaging cell lines of the invention are generated using a baculo-AAV hybrid system for stable expression of structural and regulatory lentiviral proteins, such system comprising a baculoviral backbone containing an integration cassette flanked by AAV ITR, in combination with a plasmid encoding rep protein. This system allows to obtain a stable integration of the structural and regulatory HIV-1 proteins gag/pol and rev. The system allows to obtain a first intermediate including only the structural and regulatory HIV proteins gag/pol and rev, to be used as starting point to obtain stable packaging cell lines as well as producer cell lines.


Find Patent Forward Citations

Loading…